| 15/07 | Galapagos ADRs Down After Study Data |  |
| 15/07 | SECTOR UPDATE : Health Care Stocks Flat To Lower Pre-Bell Thursday | |
| 15/07 | UPDATE : Galapagos Reports Results From Phase 1b Psoriasis Study -- Shares Slump.. | |
| 15/07 | GALAPAGOS NV : des résultats cliniques décevants |  |
| 15/07 | GALAPAGOS : N.V., - Galapagos reports positive topline results with selective TY.. | |
| 15/07 | GALAPAGOS : N.V., - Galapagos demonstrates early clinical activity with SIK2/3 i.. | |
| 15/07 | GALAPAGOS : données de phase Ib positives en psoriasis | |
| 15/07 | GALAPAGOS : Drug Shown Safe In Three Clinical Studies | |
| 15/07 | GALAPAGOS' : Psoriasis Drug Shown Safe, Well-Tolerated in Early-Stage Study | |
| 14/07 | GALAPAGOS : demonstrates early clinical activity with SIK2/3 inhibition in infla.. | |
| 14/07 | GALAPAGOS : reports positive topline results with selective TYK2 inhibitor GLPG3.. | |
| 14/07 | GALAPAGOS : GLPG3667 Shows Positive Results in Psoriasis Patients, Reports Topli.. | |
| 14/07 | GALAPAGOS : demonstrates early clinical activity with SIK2/3 inhibition in infla.. | |
| 14/07 | GALAPAGOS : reports positive topline results with selective TYK2 inhibitor GLPG3.. | |
| 14/07 | Galapagos NV Demonstrates Early Clinical Activity with SIK2/3 Inhibition in I.. | |
| 14/07 | Galapagos NV Reports Positive Topline Results with Selective TYK2 Inhibitor G.. | |
| 12/07 | GALAPAGOS : Bowel Disease Drug Shows Effect In Post-Hoc Analyses Of Late-Stage S.. | |
| 10/07 | GALAPAGOS : announces new data supporting rapid symptom improvement and sustaine.. | |
| 10/07 | Galapagos Announces New Data Supporting Rapid Symptom Improvement and Sustain.. | |
| 23/06 | GALAPAGOS : announces departure of CSO Piet Wigerinck later this year (Form 6-K) | |
| 23/06 | GALAPAGOS : Chief Scientific Officer To Step Down | |
| 22/06 | GALAPAGOS : Chief Scientific Officer to Leave Company Later This Year | |
| 22/06 | Galapagos Announces Departure of CSO Piet Wigerinck | |
| 21/06 | GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P Global 1200 | |
| 21/06 | GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P International 700 | |
| 21/06 | GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P EUROPE 350 - Pharmaceuticals, Biote.. | |
| 21/06 | GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P EUROPE 350 - Health Care | |
| 21/06 | GALAPAGOS NV(ENXTAM : GLPG) dropped from S&P EUROPE 350 | |
| 08/06 | GALAPAGOS : increases share capital through subscription right exercises (Form 6.. | |
| 07/06 | Galapagos increases share capital through subscription right exercises | |
| 04/06 | GALAPAGOS : SELECTION study on filgotinib in ulcerative colitis published in The.. | |
| 04/06 | GALAPAGOS : Anti-inflammatory Drug Jyseleca Sustains Efficacy in Maintenance Stu.. | |
| 04/06 | Galapagos NV Announces That Primary and Secondary Endpoint Results from the P.. | |
| 28/05 | GALAPAGOS : to present data on rheumatoid arthritis at the upcoming European Lea.. | |
| 27/05 | Galapagos NV to Present Data on Rheumatoid Arthritis At the Upcoming European.. | |
| 19/05 | GALAPAGOS : announces first patient enrolled in FILOSOPHY study to advance under.. | |
| 19/05 | GALAPAGOS : Enrolls First Patient in Post-Approval Study of Arthritis Drug | |
| 18/05 | GALAPAGOS : Launches Phase 4 Study of Filgotinib Rheumatoid Arthritis Medication.. | |
| 18/05 | Galapagos Announces First Patient Enrolled in FILOSOPHY Study to Advance Unde.. | |
| 18/05 | Galapagos announces first patient enrolled in FILOSOPHY study to advance unde.. | |
| 12/05 | MSCI streicht Hochtief-Aktie aus Deutschland-Index |  |
| 11/05 | GALAPAGOS : refocuses pipeline and rightsizes operations (Form 6-K) | |
| 10/05 | GALAPAGOS NV : les ambitions de croissance externe n'enthousiasment pas le march.. | |
| 10/05 | AVIS D'ANALYSTES DU JOUR : Société Générale, ArcelorMittal, Adidas, Arkema, Gal.. | |
| 04/05 | GALAPAGOS : Transparency notification received from The Capital Group | |
| 03/05 | GALAPAGOS : creates new subscription right plans | |
| 28/04 | GALAPAGOS : Written questions and answers | |
| 23/04 | Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the .. | |
| 23/04 | GALAPAGOS : Says Japanese Partner Files New Drug Application for Additional Indi.. | |
| 23/04 | e-Therapeutics Expects to Receive Payments From Galapagos | |
| 20/04 | AVIS D'ANALYSTES DU JOUR : BMW, Volkswagen, AstraZeneca, Sopra, Ipsen, Grifols,.. | |
| 09/04 | GALAPAGOS : Gilead Extends Lock-Up Period for Galapagos Shareholding | |
| 08/04 | GALAPAGOS : Extension of lock-up period in Gilead-Galapagos collaboration agreem.. | |
| 26/03 | GALAPAGOS NV : - Publication of the annual report and invitation to the ordinary.. | |
| 25/03 | GALAPAGOS : Statutory auditor's report on the non-consolidated financial stateme.. | |
| 25/03 | GALAPAGOS : Publication of the annual report and invitation to the ordinary shar.. | |
| 25/03 | GALAPAGOS : COO Takes On President Role | |
| 24/03 | GALAPAGOS : Names Bart Filius President & COO | |
| 24/03 | Galapagos Appoints Bart Filius as President and Chief Operating Officer | |
| 24/03 | Galapagos appoints Bart Filius as President and Chief Operating Officer | |
| 22/03 | GALAPAGOS NV(ENXTAM : GLPG) added to AMX Index | |
| 19/03 | GALAPAGOS : increases share capital through subscription right exercises | |
| 19/03 | GALAPAGOS NV(ENXTAM : GLPG) dropped from Amsterdam AEX Index | |
| 18/03 | Oxurion NV Business and Financial Update, FY 2020 | |
| 10/03 | GALAPAGOS : vers une sortie de l'AEX | |
| 10/03 | EN DIRECT DES MARCHES : EDF, Stellantis, Alstom, Rothschild, Voyageurs du Monde.. | |
| 04/03 | GALAPAGOS : Says Ongoing Anti-inflammatory Drug Trials Meet Primary Endpoint | |
| 04/03 | GALAPAGOS NV : - Transparency notification received from The Capital Group | |
| 04/03 | GALAPAGOS : REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-.. | |
| 04/03 | Galapagos Reports Primary Endpoint for the Ongoing Filgotinib MANTA and MANTA.. | |
| 03/03 | Transparency notification received from The Capital Group | |
| 22/02 | AVIS D'ANALYSTES DU JOUR : Kering, Hermès, Logitech, Air France, Varta, GTT, Ato.. | |
| 22/02 | GALAPAGOS : Slumps to FY20 Loss Amid Increased R&D Costs | |
| 19/02 | GALAPAGOS : Shares Rise After FY20 Results Top Expectations | |
| 19/02 | GALAPAGOS NV : - Pipeline and capital for growth | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
